Epithalon: Telomere Research and Cellular Longevity Models

Epithalon (tetrapeptide Ala-Glu-Asp-Gly) is the synthetic analogue of Epithalamin, a natural pineal gland extract, developed by Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation. Its primary research interest is telomerase activation in human somatic cells.

Telomere Biology

Telomeres are TTAGGG repeat sequences capping chromosomes, shortening with each cell division. When critically short, cells enter senescence or apoptosis. Telomerase (TERT catalytic subunit) adds new repeats — normally active only in stem cells and germline. Most somatic cells have suppressed telomerase, causing progressive telomere attrition with age.

Epithalon's Telomerase Activation

Khavinson VK et al. (*Bulletin of Experimental Biology and Medicine*, 2003) showed in human fetal fibroblasts:

• Telomerase activity in treated cells: increased approximately 2.4-fold vs controls
• Telomere length after 12 serial passages: maintained near initial length vs progressive shortening in controls
• Extended replicative lifespan: ~44 population doublings vs ~35 in controls before senescence

In Vivo Longevity Data

In 3-year studies with female C3H/He mice (Anisimov VN et al., *Mechanisms of Ageing and Development*, 2003), lifelong Epithalon administration:

• Increased maximum lifespan by 12.3%
• Reduced incidence of mammary tumors

In Wistar rats, Epithalon extended mean lifespan from 651±21 to 756±22 days (~16% increase), while reducing age-related decline in antioxidant enzyme activity.

Pineal Gland and Melatonin

Epithalon stimulates pineal melatonin synthesis. In aged rats with severely blunted melatonin rhythms, 5-day Epithalon courses (0.1 mcg/kg, IP) restored melatonin peaks to ~60% of young-adult levels within 2 weeks — potentially explaining its neuroendocrine aging effects.

Comparison to NAD+ Approaches

While NMN and NR address the energetic and sirtuin aspects of aging, Epithalon specifically addresses telomere attrition — a mechanistically distinct and non-overlapping aging hallmark. The two approaches may be complementary: SIRT1 (activated by NAD+) can phosphorylate and activate TERT, meaning restored NAD+ could enhance Epithalon's telomerase activation.

Epithalon research is primarily from the Khavinson group. No Western RCTs have been published. All findings are preclinical or from Russian observational studies.

<!-- deep-links-v1 -->

Related Longevity and Immune-Modulating Peptides

Epithalon is part of a broader class of bioregulator peptides with geroprotective research profiles. Thymalin is a thymic extract peptide with documented effects on immune restoration in aged animal models. Thymagen (Thymogen) is a dipeptide derived from thymosin that modulates T-cell differentiation. Vilon is a dipeptide bioregulator reported to extend lifespan in aged laboratory rodents. Chonluten, a tripeptide bronchial bioregulator, appears in aging research for its pulmonary tissue effects. ACTH (1-24) is referenced alongside pineal peptides for its role in the hypothalamic-pituitary axis.

Mitochondrial and Cellular Aging Peptides

Humanin, a mitochondria-derived peptide (MOTS-c family member), shows cytoprotective effects against Alzheimer's and metabolic stress models. SHLP-2 (Small Humanin-Like Peptide 2), another mitochondrially encoded peptide, shows anti-apoptotic activity in beta-cell models. Endoluten, a pineal peptide bioregulator, is studied alongside epithalon for pineal axis support and circadian modulation. FOXo4-DRI, the senolytic peptide that selectively induces apoptosis in senescent cells, represents a mechanistically distinct approach to geroprotection. NAD+ (nicotinamide adenine dinucleotide) functions as a coenzyme central to mitochondrial energy metabolism and is frequently discussed in the context of peptide-based aging interventions.